Literature DB >> 7902846

Differential regulation of natriuretic peptide receptor messenger RNAs during the development of cardiac hypertrophy in the rat.

L A Brown1, D J Nunez, M R Wilkins.   

Abstract

The heart expresses the three natriuretic peptide receptors (NPR), namely NPR-A, NPR-B, and NPR-C. We have examined the temporal relationship between the expression of mRNA transcripts for atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) and their receptors in the heart during the development of cardiac hypertrophy in the aortovenocaval fistula rat. Messenger RNAs were measured by cDNA amplification. Progressive cardiac hypertrophy was accompanied by increased ANP mRNA prevalence throughout the heart and increased BNP mRNA in the left atrium. The most striking observation was the gradual disappearance of NPR-C transcripts (the putative "clearance" receptor) in all chambers; this was in marked contrast to the increase in mRNA levels for NPR-A and NPR-B (the guanylyl cyclase-linked receptors). Our observations have important therapeutic implications if the transcript changes are mirrored at the receptor protein level because (a) the apparent down-regulation of NPR-C may enhance the local action of natriuretic peptides on the heart, and (b) the loss of NPR-C, particularly if it is widespread, may reduce the rate of elimination of the natriuretic peptides, restricting the therapeutic potential of specific NPR-C ligands designed to reduce peptide clearance.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7902846      PMCID: PMC288468          DOI: 10.1172/JCI116887

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  86 in total

1.  Endocardial localization and characterization of natriuretic peptide binding sites in human fetal and adult heart.

Authors:  R A Rutherford; J Wharton; L Gordon; G Moscoso; M H Yacoub; J M Polak
Journal:  Eur J Pharmacol       Date:  1992-02-25       Impact factor: 4.432

2.  Methods for studying the platelet-derived growth factor receptor.

Authors:  D F Bowen-Pope; R Ross
Journal:  Methods Enzymol       Date:  1985       Impact factor: 1.600

3.  Morphometric analysis of collagen network and plasma perfused capillary bed in the myocardium of rats during evolution of cardiac hypertrophy.

Authors:  J B Michel; J L Salzmann; M Ossondo Nlom; P Bruneval; D Barres; J P Camilleri
Journal:  Basic Res Cardiol       Date:  1986 Mar-Apr       Impact factor: 17.165

4.  Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family.

Authors:  P Fort; L Marty; M Piechaczyk; S el Sabrouty; C Dani; P Jeanteur; J M Blanchard
Journal:  Nucleic Acids Res       Date:  1985-03-11       Impact factor: 16.971

5.  Cloning and sequence analysis of a cDNA encoding a precursor for rat C-type natriuretic peptide (CNP).

Authors:  M Kojima; N Minamino; K Kangawa; H Matsuo
Journal:  FEBS Lett       Date:  1990-12-10       Impact factor: 4.124

6.  Hemodynamic changes in rats after opening an arteriovenous fistula.

Authors:  M Huang; R L Hester; A C Guyton
Journal:  Am J Physiol       Date:  1992-03

7.  Radioautographic localization of 125I-atrial natriuretic factor (ANF) in rat tissues.

Authors:  C Bianchi; J Gutkowska; G Thibault; R Garcia; J Genest; M Cantin
Journal:  Histochemistry       Date:  1985

8.  Biosynthesis and secretion of proatrial natriuretic factor by cultured rat cardiocytes.

Authors:  K D Bloch; J A Scott; J B Zisfein; J T Fallon; M N Margolies; C E Seidman; G R Matsueda; C J Homcy; R M Graham; J G Seidman
Journal:  Science       Date:  1985-12-06       Impact factor: 47.728

9.  Neuromodulatory effects of atrial natriuretic factor are independent of guanylate cyclase in adrenergic neuronal pheochromocytoma cells.

Authors:  J G Drewett; R J Ziegler; G J Trachte
Journal:  J Pharmacol Exp Ther       Date:  1990-11       Impact factor: 4.030

10.  Localization of specific binding sites for atrial natriuretic factor in peripheral tissues of the guinea pig, rat, and human.

Authors:  C R Mantyh; L Kruger; N C Brecha; P W Mantyh
Journal:  Hypertension       Date:  1986-08       Impact factor: 10.190

View more
  13 in total

1.  Increased guanylate cyclase activity is associated with an increase in cyclic guanosine 3',5'-monophosphate in left ventricular hypertrophy.

Authors:  J D Sadoff; P M Scholz; J Tse; H R Weiss
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  Emodin and emodin-rich rhubarb inhibits histone deacetylase (HDAC) activity and cardiac myocyte hypertrophy.

Authors:  Levi W Evans; Abigail Bender; Leah Burnett; Luis Godoy; Yi Shen; Dante Staten; Tong Zhou; Jeffrey E Angermann; Bradley S Ferguson
Journal:  J Nutr Biochem       Date:  2020-01-10       Impact factor: 6.048

3.  Renal effects of concurrent E-24.11 and ACE inhibition in the aorto-venocaval fistula rat.

Authors:  J E Kirk; M R Wilkins
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

4.  Prolonged atrial natriuretic peptide exposure stimulates guanylyl cyclase-a degradation.

Authors:  Darcy R Flora; Lincoln R Potter
Journal:  Endocrinology       Date:  2010-04-09       Impact factor: 4.736

Review 5.  Biochemistry and physiology of the natriuretic peptide receptor guanylyl cyclases.

Authors:  Johanne Tremblay; Richard Desjardins; David Hum; Jolanta Gutkowska; Pavel Hamet
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

6.  The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system.

Authors:  N Matsukawa; W J Grzesik; N Takahashi; K N Pandey; S Pang; M Yamauchi; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

7.  Ligand-mediated endocytosis and intracellular sequestration of guanylyl cyclase/natriuretic peptide receptors: role of GDAY motif.

Authors:  Kailash N Pandey
Journal:  Mol Cell Biochem       Date:  2009-11-26       Impact factor: 3.396

8.  Direct chronotropic effects of atrial and C-type natriuretic peptides in anaesthetized dogs.

Authors:  P Beaulieu; R Cardinal; A De Léan; C Lambert
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

9.  Novel protein therapeutics for systolic heart failure: chronic subcutaneous B-type natriuretic peptide.

Authors:  Horng H Chen; James F Glockner; John A Schirger; Alessandro Cataliotti; Margaret M Redfield; John C Burnett
Journal:  J Am Coll Cardiol       Date:  2012-11-01       Impact factor: 24.094

10.  Inhibition of nitric oxide synthesis in vascular smooth muscle by retinoids.

Authors:  K Hirokawa; K M O'Shaughnessy; P Ramrakha; M R Wilkins
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.